The data was reported in a study by Health Track, a new public health group based at Georgetown University in Washington and financed by the Pew Charitable Trusts.
Data was reported as mean ± SD (n = 3).
Lack of details about patients' clinical data was reported to be one of the limitations of the study [6].
The continuous data was reported for each trial arm as mean, standard deviation (SD) and group size.
The total N for each group at each timepoint represents the number of patients for whom data was reported.
The energy release per mass data was reported, but the method for determining that data was not reported.
Kinase activity data was reported as the percent remaining kinase activity in test compounds compared to the solvent control dimethyl sulfoxide (DMSO).
The remaining two were judged to be at low risk as outcome data was reported for almost all cases [27, 33, 34].
However, despite the increased variability, since our original data was reported using the mean of four measurements any random measurement error should cancel out.
The report published today on bioRxiv is only a partial one, put out because the researchers felt it worthwhile to do so after some of the data was reported on by the website Microwave News.
While the scientific and the summary conclusions remain the same, some of the specific data was reported incorrectly.
